Strategies of hepatitis C virus elimination for people who inject drugs receiving opioid agonist therapy in the era of direct‐acting antivirals

Documenti analoghi

• Treatment in noncirrhotic and low‐viral‐load chronic hepatitis B
  di: Chao‐Hung Hung
  Pubblicazione: (2025)
• Distinct gut microbiota alterations in patients with early‐stage and advanced‐stage hepatocellular carcinoma
  di: Ming‐Chao Tsai, et al.
  Pubblicazione: (2024)
• Efficacy of pangenotypic direct‐acting antivirals in treating hepatitis C virus infection: A comparative analysis of urban and rural settings
  di: Hsing‐Jung Yeh, et al.
  Pubblicazione: (2025)
• An unusual presentation of ischemic bowel disease
  di: Chien‐Tzu Hung, et al.
  Pubblicazione: (2024)
• 11‐3: Invited Paper: Advanced Micro LED Technologies for AR/MR Systems
  di: Chien-Chung Lin, et al.
  Pubblicazione: (2024)